Real‐world evaluation of capillary microsampling for drug monitoring of anti‐seizure medications
Open Access
Abstract
Objective: Capillary microsampling offers a minimally invasive alternative to venipuncture for therapeutic drug monitoring (TDM) of anti‐seizure medications (ASMs). We evaluated the feasibility and reliability of volumetric absorptive microsampling (VAMS) and quantitative dried blood spot (qDBS) devices for ambulatory self‐collection and at‐home use in persons with epilepsy (PwE). Methods: PwE attending the Epilepsy Centre of the IRCCS‐Istituto delle Scienze Neurologiche di Bologna (Italy) were enrolled between October 2023 and October 2024. Participants performed supervised self‐collection using VAMS and qDBS in ambulatory setting and at‐home self‐collection with VAMS devices. Sample quality, delivery success, and patient‐reported outcomes (ease, pain, and clarity of instructions) were recorded. Carbamazepine, lacosamide, lamotrigine, and levetiracetam were quantified using a validated ultra‐high performance liquid chromatography‐tandem mass spectrometry (UHPLC–MS/MS) method. Reliability was assessed by comparing at‐home VAMS with ambulatory VAMS and cross‐validating qDBS with VAMS and venous plasma samples using Bland–Altman analysis and linear regression. Results: A total of 105 PwE (66% female, mean age 41 years) performed at‐home and ambulatory self‐collection using VAMS and qDBS devices. Most at‐home VAMS samples (88%) were received by the laboratory within 7 days, and 86.8% met high‐quality criteria. For lacosamide, lamotrigine, and levetiracetam, we found strong correlations between at‐home and ambulatory VAMS (Pearson's r ranging from .88 to .98) and low mean bias (60 years impacted sampling quality, particularly for qDBS ( p = .04). Significance: VAMS‐based self‐collection is feasible and reliable for at‐home TDM, provided that high‐quality sampling is ensured. qDBS represents a reliable alternative for ambulatory monitoring. Future work should focus on optimizing sampling procedures for older adults and improving logistics for home‐based microsampling.Keywords
This publication has 29 references indexed in Scilit:
- Quantitative dried blood spot microsampling for therapeutic drug monitoring of -antiseizure medications by design of experiment and UHPLC-MS/MSTalanta, 2025
- Volumetric absorptive microsampling coupled with UHPLC-MS/MS for the determination of Lyso-Gb3 as Fabry disease diagnostic biomarkerMicrochemical Journal, 2024
- Fingerprick volumetric absorptive microsampling for therapeutic drug monitoring of antiseizure medications: Reliability and real-life feasibility in epilepsy patientsJournal of Pharmaceutical and Biomedical Analysis, 2024
- Use of volumetric absorptive microsampling and parallel reaction monitoring mass spectrometry for tacrolimus blood trough measurements at home in pediatric heart transplant patientsJournal of Mass Spectrometry and Advances in the Clinical Lab, 2024
- Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer® qDBS deviceAnalytica Chimica Acta, 2023
- Predicting blood-to-plasma concentration ratios of drugs from chemical structures and volumes of distribution in humansMolecular Diversity, 2021
- Is the hematocrit still an issue in quantitative dried blood spot analysis?Journal of Pharmaceutical and Biomedical Analysis, 2019
- Tutorial: Volumetric absorptive microsampling (VAMS)Analytica Chimica Acta, 2019
- Volumetric absorptive microsampling as an alternative tool for therapeutic drug monitoring of first-generation anti-epileptic drugsAnalytical and Bioanalytical Chemistry, 2018
- Volumetric absorptive microsampling: Current advances and applicationsJournal of Pharmaceutical and Biomedical Analysis, 2018